Bitcoin ETFs $68M outflow as Ark, Fidelity draw inflows

Bitcoin ETFs posted $68.18 million in net outflows on June 22, despite $121.38 million of combined inflows into Ark & 21Shares’ ARKB and Fidelity’s FBTC.

On June 22, bitcoin exchange-traded funds recorded $68.18 million in net outflows. Inflows into several funds were outweighed by large redemptions from two major products.

Ark & 21Shares’ ARKB led incoming flows with $64.00 million and Fidelity’s FBTC attracted $57.38 million. Grayscale’s Bitcoin Mini Trust added $48.14 million, Morgan Stanley’s MSBT drew $8.11 million, Franklin’s EZBC received $3.72 million and WisdomTree’s BTCW took in $3.40 million.

BlackRock’s IBIT experienced $171.96 million in withdrawals and Grayscale’s GBTC lost $80.96 million. Total value traded across bitcoin ETFs on the day was $1.87 billion and aggregate net assets in the category closed at $80.22 billion.

Ether-focused ETFs recorded $66.38 million in net outflows, with most of that movement tied to BlackRock’s ETHA. 21Shares’ TETH registered a $346,070 inflow. Ether ETF trading volume was $433.10 million and total net assets across the category ended at $9.44 billion.

XRP ETFs posted $5.31 million in net inflows, all into Bitwise’s XRP product. XRP ETFs traded $15.05 million and held $993.29 million in net assets after the session.

Solana-based ETFs reported no trading activity and closed with $836.09 million in assets. HYPE-branded ETFs also saw no trades and finished the day with $219.58 million in net assets.

Combined net flows for bitcoin and ether ETFs on June 22 totaled $134.56 million in outflows.

The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.

Articles by this author